NHS Surrey Heath CCG manages the budget for prescriptions issued by GPs - around £12m each year.

Each year, around £430,000 of prescribed medicine is wasted because it is not used by patients and has to be disposed of safely.  Once prescribed and dispensed, medicines cannot be used again.

The CCG is encouraging people to use medicine wisely - only ask for repeat prescriptions you need and will use.  If you have been prescribed medication by your doctor follow the instructions and finish the course.

End of Life Care

Click here to view a list of community pharmacies included in the on demand availability of drugs for palliative care in the Surrey area.

For further details on end of life care and the support available please click here.

Generic Medicines

NHS Surrey Heath is responsible for managing the drugs budget spent by doctors in our area. During 2016 more than £12 million was spent in Surrey Heath on over a million prescription items. It is also important that we make best use of the money we spend on medicines, without reducing the quality of the treatment patients receive. If more money is spent on medicines than is available, the extra money has to come from other areas of healthcare. This means that we may not be able to provide all the services we would like.

The CCG supports the use of generic medicines in the right patients as a way to make the best use of our resources.You can find further information in our pdf patient leaflet (622 KB) . A non-routine Medicine Funding Request (NMFR) Form is available pdf here. (386 KB)

FreeStyle Libre® Device

Surrey Heath Clinical CCG is continuing to work with other Frimley Health facing CCGs and Frimley Park Hospital to consider the safe and appropriate use of the FreeStyle Libre® device for those with Type one diabetes.  Local specialists will be participating in a national audit and the evidence gathered will inform future recommendations. 

The CCG  is committed to providing the most effective, fair and sustainable use of finite resources using the clinical evidence available to inform the decisions made. As commissioners we need to ensure that any new medicines and devices are considered to be safe, cost effective and that NHS resources are used efficiently.